PANCREAS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=804780, encodeId=a609804e8057, content=收case report嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e8e5400378, createdName=ms4000001486715549, createdTime=Mon Jul 27 20:15:44 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114136, encodeId=2e6b2114136c9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌;胰腺外科;胰腺 经验分享：避坑提示：《Pancreas》这个杂志真的不能投，2022年1月18号投，2023年1月10号接收（online还遥遥无期），回修1次，提了一大堆无聊的格式和语言问题，中途催了无数次状态，邮件不回，电话不接。当年还算胰腺病领域的老牌杂志，所有杂志都在IF看涨，现在一年只出10期（今天才出到去年9月份），混到中科院4区4类。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/7ba6775a3b72447cb8b000d29c451fe9/2e486272414e4328a364dd1dd41976ee.jpg, createdBy=96881963893, createdName=Chong Yang, createdTime=Sat Feb 11 17:28:59 CST 2023, time=2023-02-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112132, encodeId=ffcd211213226, content=Required Reviews Completed状态到底要多久！！！！从5月1日到现在了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad6b6541939, createdName=ms9000000675256751, createdTime=Mon Jan 30 15:55:15 CST 2023, time=2023-01-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2091443, encodeId=ba6f209144334, content=under review 2周后，状态转为Required Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Sun Oct 02 10:25:09 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110678, encodeId=e4df21106e878, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌 经验分享：请问如何撤稿？投稿9个月没有动静，给编辑部发了3封催稿邮件从不回复。已经对此刊死心了，打算改投。请问如何撤稿？通过通讯作者邮箱给这个E-mail地址pancreasofc@ucla.edu告知撤稿就可以了吗？编辑部的人好像都死了，怎么问询也不会回邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Wed Jan 18 08:18:15 CST 2023, time=2023-01-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=548013, encodeId=20ee548013e7, content=请问有相似经验的小伙伴吗，pancreas投了快2个月了，还是submitted to journal ，发了邮件也没消息，想知道怎么回事？谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1eea2163064, createdName=120372d6m60(暂无昵称), createdTime=Sun Oct 08 19:20:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239524, encodeId=b343123952488, content=偏重的研究方向：胰腺炎;胰腺癌 经验分享：此刊慎投。投了4个月，一直是“Reviewer invited”状态，发邮件给推荐审稿人也不回复，气死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Thu Aug 18 14:56:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243394, encodeId=c0c91243394eb, content=审稿速度:6.0 经验分享：投了5个多月了，还没消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1e4839601, createdName=songyd, createdTime=Mon Sep 05 22:52:48 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103342, encodeId=f1b8210334264, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：以后不会再投了，影响因子低，周期长，编辑也从来不理人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80bd1682976, createdName=DengLH, createdTime=Tue Nov 29 17:20:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2095775, encodeId=eb7f2095e75df, content=请问一下，投稿过程中总是addition information出问题是怎么回事啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad98393587, createdName=ms9000001100975757, createdTime=Mon Oct 24 11:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=)]

2020-07-27 ms4000001486715549

收case report嘛

177 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=804780, encodeId=a609804e8057, content=收case report嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e8e5400378, createdName=ms4000001486715549, createdTime=Mon Jul 27 20:15:44 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114136, encodeId=2e6b2114136c9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌;胰腺外科;胰腺 经验分享：避坑提示：《Pancreas》这个杂志真的不能投，2022年1月18号投，2023年1月10号接收（online还遥遥无期），回修1次，提了一大堆无聊的格式和语言问题，中途催了无数次状态，邮件不回，电话不接。当年还算胰腺病领域的老牌杂志，所有杂志都在IF看涨，现在一年只出10期（今天才出到去年9月份），混到中科院4区4类。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/7ba6775a3b72447cb8b000d29c451fe9/2e486272414e4328a364dd1dd41976ee.jpg, createdBy=96881963893, createdName=Chong Yang, createdTime=Sat Feb 11 17:28:59 CST 2023, time=2023-02-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112132, encodeId=ffcd211213226, content=Required Reviews Completed状态到底要多久！！！！从5月1日到现在了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad6b6541939, createdName=ms9000000675256751, createdTime=Mon Jan 30 15:55:15 CST 2023, time=2023-01-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2091443, encodeId=ba6f209144334, content=under review 2周后，状态转为Required Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Sun Oct 02 10:25:09 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110678, encodeId=e4df21106e878, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌 经验分享：请问如何撤稿？投稿9个月没有动静，给编辑部发了3封催稿邮件从不回复。已经对此刊死心了，打算改投。请问如何撤稿？通过通讯作者邮箱给这个E-mail地址pancreasofc@ucla.edu告知撤稿就可以了吗？编辑部的人好像都死了，怎么问询也不会回邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Wed Jan 18 08:18:15 CST 2023, time=2023-01-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=548013, encodeId=20ee548013e7, content=请问有相似经验的小伙伴吗，pancreas投了快2个月了，还是submitted to journal ，发了邮件也没消息，想知道怎么回事？谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1eea2163064, createdName=120372d6m60(暂无昵称), createdTime=Sun Oct 08 19:20:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239524, encodeId=b343123952488, content=偏重的研究方向：胰腺炎;胰腺癌 经验分享：此刊慎投。投了4个月，一直是“Reviewer invited”状态，发邮件给推荐审稿人也不回复，气死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Thu Aug 18 14:56:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243394, encodeId=c0c91243394eb, content=审稿速度:6.0 经验分享：投了5个多月了，还没消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1e4839601, createdName=songyd, createdTime=Mon Sep 05 22:52:48 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103342, encodeId=f1b8210334264, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：以后不会再投了，影响因子低，周期长，编辑也从来不理人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80bd1682976, createdName=DengLH, createdTime=Tue Nov 29 17:20:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2095775, encodeId=eb7f2095e75df, content=请问一下，投稿过程中总是addition information出问题是怎么回事啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad98393587, createdName=ms9000001100975757, createdTime=Mon Oct 24 11:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=)]

2023-02-11 Chong Yang 来自四川省

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：胰腺癌;胰腺外科;胰腺
经验分享：避坑提示：《Pancreas》这个杂志真的不能投，2022年1月18号投，2023年1月10号接收（online还遥遥无期），回修1次，提了一大堆无聊的格式和语言问题，中途催了无数次状态，邮件不回，电话不接。当年还算胰腺病领域的老牌杂志，所有杂志都在IF看涨，现在一年只出10期（今天才出到去年9月份），混到中科院4区4类。

78 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=804780, encodeId=a609804e8057, content=收case report嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e8e5400378, createdName=ms4000001486715549, createdTime=Mon Jul 27 20:15:44 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114136, encodeId=2e6b2114136c9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌;胰腺外科;胰腺 经验分享：避坑提示：《Pancreas》这个杂志真的不能投，2022年1月18号投，2023年1月10号接收（online还遥遥无期），回修1次，提了一大堆无聊的格式和语言问题，中途催了无数次状态，邮件不回，电话不接。当年还算胰腺病领域的老牌杂志，所有杂志都在IF看涨，现在一年只出10期（今天才出到去年9月份），混到中科院4区4类。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/7ba6775a3b72447cb8b000d29c451fe9/2e486272414e4328a364dd1dd41976ee.jpg, createdBy=96881963893, createdName=Chong Yang, createdTime=Sat Feb 11 17:28:59 CST 2023, time=2023-02-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112132, encodeId=ffcd211213226, content=Required Reviews Completed状态到底要多久！！！！从5月1日到现在了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad6b6541939, createdName=ms9000000675256751, createdTime=Mon Jan 30 15:55:15 CST 2023, time=2023-01-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2091443, encodeId=ba6f209144334, content=under review 2周后，状态转为Required Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Sun Oct 02 10:25:09 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110678, encodeId=e4df21106e878, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌 经验分享：请问如何撤稿？投稿9个月没有动静，给编辑部发了3封催稿邮件从不回复。已经对此刊死心了，打算改投。请问如何撤稿？通过通讯作者邮箱给这个E-mail地址pancreasofc@ucla.edu告知撤稿就可以了吗？编辑部的人好像都死了，怎么问询也不会回邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Wed Jan 18 08:18:15 CST 2023, time=2023-01-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=548013, encodeId=20ee548013e7, content=请问有相似经验的小伙伴吗，pancreas投了快2个月了，还是submitted to journal ，发了邮件也没消息，想知道怎么回事？谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1eea2163064, createdName=120372d6m60(暂无昵称), createdTime=Sun Oct 08 19:20:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239524, encodeId=b343123952488, content=偏重的研究方向：胰腺炎;胰腺癌 经验分享：此刊慎投。投了4个月，一直是“Reviewer invited”状态，发邮件给推荐审稿人也不回复，气死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Thu Aug 18 14:56:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243394, encodeId=c0c91243394eb, content=审稿速度:6.0 经验分享：投了5个多月了，还没消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1e4839601, createdName=songyd, createdTime=Mon Sep 05 22:52:48 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103342, encodeId=f1b8210334264, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：以后不会再投了，影响因子低，周期长，编辑也从来不理人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80bd1682976, createdName=DengLH, createdTime=Tue Nov 29 17:20:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2095775, encodeId=eb7f2095e75df, content=请问一下，投稿过程中总是addition information出问题是怎么回事啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad98393587, createdName=ms9000001100975757, createdTime=Mon Oct 24 11:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=)]

2023-01-30 ms9000000675256751 来自福建省

Required Reviews Completed状态到底要多久！！！！从5月1日到现在了

67 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=804780, encodeId=a609804e8057, content=收case report嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e8e5400378, createdName=ms4000001486715549, createdTime=Mon Jul 27 20:15:44 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114136, encodeId=2e6b2114136c9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌;胰腺外科;胰腺 经验分享：避坑提示：《Pancreas》这个杂志真的不能投，2022年1月18号投，2023年1月10号接收（online还遥遥无期），回修1次，提了一大堆无聊的格式和语言问题，中途催了无数次状态，邮件不回，电话不接。当年还算胰腺病领域的老牌杂志，所有杂志都在IF看涨，现在一年只出10期（今天才出到去年9月份），混到中科院4区4类。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/7ba6775a3b72447cb8b000d29c451fe9/2e486272414e4328a364dd1dd41976ee.jpg, createdBy=96881963893, createdName=Chong Yang, createdTime=Sat Feb 11 17:28:59 CST 2023, time=2023-02-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112132, encodeId=ffcd211213226, content=Required Reviews Completed状态到底要多久！！！！从5月1日到现在了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad6b6541939, createdName=ms9000000675256751, createdTime=Mon Jan 30 15:55:15 CST 2023, time=2023-01-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2091443, encodeId=ba6f209144334, content=under review 2周后，状态转为Required Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Sun Oct 02 10:25:09 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110678, encodeId=e4df21106e878, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌 经验分享：请问如何撤稿？投稿9个月没有动静，给编辑部发了3封催稿邮件从不回复。已经对此刊死心了，打算改投。请问如何撤稿？通过通讯作者邮箱给这个E-mail地址pancreasofc@ucla.edu告知撤稿就可以了吗？编辑部的人好像都死了，怎么问询也不会回邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Wed Jan 18 08:18:15 CST 2023, time=2023-01-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=548013, encodeId=20ee548013e7, content=请问有相似经验的小伙伴吗，pancreas投了快2个月了，还是submitted to journal ，发了邮件也没消息，想知道怎么回事？谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1eea2163064, createdName=120372d6m60(暂无昵称), createdTime=Sun Oct 08 19:20:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239524, encodeId=b343123952488, content=偏重的研究方向：胰腺炎;胰腺癌 经验分享：此刊慎投。投了4个月，一直是“Reviewer invited”状态，发邮件给推荐审稿人也不回复，气死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Thu Aug 18 14:56:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243394, encodeId=c0c91243394eb, content=审稿速度:6.0 经验分享：投了5个多月了，还没消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1e4839601, createdName=songyd, createdTime=Mon Sep 05 22:52:48 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103342, encodeId=f1b8210334264, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：以后不会再投了，影响因子低，周期长，编辑也从来不理人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80bd1682976, createdName=DengLH, createdTime=Tue Nov 29 17:20:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2095775, encodeId=eb7f2095e75df, content=请问一下，投稿过程中总是addition information出问题是怎么回事啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad98393587, createdName=ms9000001100975757, createdTime=Mon Oct 24 11:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=)]

2022-10-02 瑶瑶童

under review 2周后，状态转为Required Reviews Completed

87 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=804780, encodeId=a609804e8057, content=收case report嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e8e5400378, createdName=ms4000001486715549, createdTime=Mon Jul 27 20:15:44 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114136, encodeId=2e6b2114136c9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌;胰腺外科;胰腺 经验分享：避坑提示：《Pancreas》这个杂志真的不能投，2022年1月18号投，2023年1月10号接收（online还遥遥无期），回修1次，提了一大堆无聊的格式和语言问题，中途催了无数次状态，邮件不回，电话不接。当年还算胰腺病领域的老牌杂志，所有杂志都在IF看涨，现在一年只出10期（今天才出到去年9月份），混到中科院4区4类。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/7ba6775a3b72447cb8b000d29c451fe9/2e486272414e4328a364dd1dd41976ee.jpg, createdBy=96881963893, createdName=Chong Yang, createdTime=Sat Feb 11 17:28:59 CST 2023, time=2023-02-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112132, encodeId=ffcd211213226, content=Required Reviews Completed状态到底要多久！！！！从5月1日到现在了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad6b6541939, createdName=ms9000000675256751, createdTime=Mon Jan 30 15:55:15 CST 2023, time=2023-01-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2091443, encodeId=ba6f209144334, content=under review 2周后，状态转为Required Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Sun Oct 02 10:25:09 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110678, encodeId=e4df21106e878, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌 经验分享：请问如何撤稿？投稿9个月没有动静，给编辑部发了3封催稿邮件从不回复。已经对此刊死心了，打算改投。请问如何撤稿？通过通讯作者邮箱给这个E-mail地址pancreasofc@ucla.edu告知撤稿就可以了吗？编辑部的人好像都死了，怎么问询也不会回邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Wed Jan 18 08:18:15 CST 2023, time=2023-01-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=548013, encodeId=20ee548013e7, content=请问有相似经验的小伙伴吗，pancreas投了快2个月了，还是submitted to journal ，发了邮件也没消息，想知道怎么回事？谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1eea2163064, createdName=120372d6m60(暂无昵称), createdTime=Sun Oct 08 19:20:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239524, encodeId=b343123952488, content=偏重的研究方向：胰腺炎;胰腺癌 经验分享：此刊慎投。投了4个月，一直是“Reviewer invited”状态，发邮件给推荐审稿人也不回复，气死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Thu Aug 18 14:56:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243394, encodeId=c0c91243394eb, content=审稿速度:6.0 经验分享：投了5个多月了，还没消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1e4839601, createdName=songyd, createdTime=Mon Sep 05 22:52:48 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103342, encodeId=f1b8210334264, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：以后不会再投了，影响因子低，周期长，编辑也从来不理人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80bd1682976, createdName=DengLH, createdTime=Tue Nov 29 17:20:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2095775, encodeId=eb7f2095e75df, content=请问一下，投稿过程中总是addition information出问题是怎么回事啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad98393587, createdName=ms9000001100975757, createdTime=Mon Oct 24 11:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=)]

2023-01-18 ms1859105519819171 来自天津

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：胰腺癌
经验分享：请问如何撤稿？投稿9个月没有动静，给编辑部发了3封催稿邮件从不回复。已经对此刊死心了，打算改投。请问如何撤稿？通过通讯作者邮箱给这个E-mail地址pancreasofc@ucla.edu告知撤稿就可以了吗？编辑部的人好像都死了，怎么问询也不会回邮件。

117 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=804780, encodeId=a609804e8057, content=收case report嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e8e5400378, createdName=ms4000001486715549, createdTime=Mon Jul 27 20:15:44 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114136, encodeId=2e6b2114136c9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌;胰腺外科;胰腺 经验分享：避坑提示：《Pancreas》这个杂志真的不能投，2022年1月18号投，2023年1月10号接收（online还遥遥无期），回修1次，提了一大堆无聊的格式和语言问题，中途催了无数次状态，邮件不回，电话不接。当年还算胰腺病领域的老牌杂志，所有杂志都在IF看涨，现在一年只出10期（今天才出到去年9月份），混到中科院4区4类。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/7ba6775a3b72447cb8b000d29c451fe9/2e486272414e4328a364dd1dd41976ee.jpg, createdBy=96881963893, createdName=Chong Yang, createdTime=Sat Feb 11 17:28:59 CST 2023, time=2023-02-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112132, encodeId=ffcd211213226, content=Required Reviews Completed状态到底要多久！！！！从5月1日到现在了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad6b6541939, createdName=ms9000000675256751, createdTime=Mon Jan 30 15:55:15 CST 2023, time=2023-01-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2091443, encodeId=ba6f209144334, content=under review 2周后，状态转为Required Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Sun Oct 02 10:25:09 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110678, encodeId=e4df21106e878, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌 经验分享：请问如何撤稿？投稿9个月没有动静，给编辑部发了3封催稿邮件从不回复。已经对此刊死心了，打算改投。请问如何撤稿？通过通讯作者邮箱给这个E-mail地址pancreasofc@ucla.edu告知撤稿就可以了吗？编辑部的人好像都死了，怎么问询也不会回邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Wed Jan 18 08:18:15 CST 2023, time=2023-01-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=548013, encodeId=20ee548013e7, content=请问有相似经验的小伙伴吗，pancreas投了快2个月了，还是submitted to journal ，发了邮件也没消息，想知道怎么回事？谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1eea2163064, createdName=120372d6m60(暂无昵称), createdTime=Sun Oct 08 19:20:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239524, encodeId=b343123952488, content=偏重的研究方向：胰腺炎;胰腺癌 经验分享：此刊慎投。投了4个月，一直是“Reviewer invited”状态，发邮件给推荐审稿人也不回复，气死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Thu Aug 18 14:56:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243394, encodeId=c0c91243394eb, content=审稿速度:6.0 经验分享：投了5个多月了，还没消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1e4839601, createdName=songyd, createdTime=Mon Sep 05 22:52:48 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103342, encodeId=f1b8210334264, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：以后不会再投了，影响因子低，周期长，编辑也从来不理人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80bd1682976, createdName=DengLH, createdTime=Tue Nov 29 17:20:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2095775, encodeId=eb7f2095e75df, content=请问一下，投稿过程中总是addition information出问题是怎么回事啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad98393587, createdName=ms9000001100975757, createdTime=Mon Oct 24 11:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=)]

2017-10-08 120372d6m60(暂无昵称)

请问有相似经验的小伙伴吗，pancreas投了快2个月了，还是submitted to journal ，发了邮件也没消息，想知道怎么回事？谢谢了！

351 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=804780, encodeId=a609804e8057, content=收case report嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e8e5400378, createdName=ms4000001486715549, createdTime=Mon Jul 27 20:15:44 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114136, encodeId=2e6b2114136c9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌;胰腺外科;胰腺 经验分享：避坑提示：《Pancreas》这个杂志真的不能投，2022年1月18号投，2023年1月10号接收（online还遥遥无期），回修1次，提了一大堆无聊的格式和语言问题，中途催了无数次状态，邮件不回，电话不接。当年还算胰腺病领域的老牌杂志，所有杂志都在IF看涨，现在一年只出10期（今天才出到去年9月份），混到中科院4区4类。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/7ba6775a3b72447cb8b000d29c451fe9/2e486272414e4328a364dd1dd41976ee.jpg, createdBy=96881963893, createdName=Chong Yang, createdTime=Sat Feb 11 17:28:59 CST 2023, time=2023-02-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112132, encodeId=ffcd211213226, content=Required Reviews Completed状态到底要多久！！！！从5月1日到现在了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad6b6541939, createdName=ms9000000675256751, createdTime=Mon Jan 30 15:55:15 CST 2023, time=2023-01-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2091443, encodeId=ba6f209144334, content=under review 2周后，状态转为Required Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Sun Oct 02 10:25:09 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110678, encodeId=e4df21106e878, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌 经验分享：请问如何撤稿？投稿9个月没有动静，给编辑部发了3封催稿邮件从不回复。已经对此刊死心了，打算改投。请问如何撤稿？通过通讯作者邮箱给这个E-mail地址pancreasofc@ucla.edu告知撤稿就可以了吗？编辑部的人好像都死了，怎么问询也不会回邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Wed Jan 18 08:18:15 CST 2023, time=2023-01-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=548013, encodeId=20ee548013e7, content=请问有相似经验的小伙伴吗，pancreas投了快2个月了，还是submitted to journal ，发了邮件也没消息，想知道怎么回事？谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1eea2163064, createdName=120372d6m60(暂无昵称), createdTime=Sun Oct 08 19:20:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239524, encodeId=b343123952488, content=偏重的研究方向：胰腺炎;胰腺癌 经验分享：此刊慎投。投了4个月，一直是“Reviewer invited”状态，发邮件给推荐审稿人也不回复，气死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Thu Aug 18 14:56:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243394, encodeId=c0c91243394eb, content=审稿速度:6.0 经验分享：投了5个多月了，还没消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1e4839601, createdName=songyd, createdTime=Mon Sep 05 22:52:48 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103342, encodeId=f1b8210334264, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：以后不会再投了，影响因子低，周期长，编辑也从来不理人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80bd1682976, createdName=DengLH, createdTime=Tue Nov 29 17:20:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2095775, encodeId=eb7f2095e75df, content=请问一下，投稿过程中总是addition information出问题是怎么回事啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad98393587, createdName=ms9000001100975757, createdTime=Mon Oct 24 11:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=)]

2022-08-18 ms1859105519819171

偏重的研究方向：胰腺炎;胰腺癌
经验分享：此刊慎投。投了4个月，一直是“Reviewer invited”状态，发邮件给推荐审稿人也不回复，气死人了。

82 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=804780, encodeId=a609804e8057, content=收case report嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e8e5400378, createdName=ms4000001486715549, createdTime=Mon Jul 27 20:15:44 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114136, encodeId=2e6b2114136c9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌;胰腺外科;胰腺 经验分享：避坑提示：《Pancreas》这个杂志真的不能投，2022年1月18号投，2023年1月10号接收（online还遥遥无期），回修1次，提了一大堆无聊的格式和语言问题，中途催了无数次状态，邮件不回，电话不接。当年还算胰腺病领域的老牌杂志，所有杂志都在IF看涨，现在一年只出10期（今天才出到去年9月份），混到中科院4区4类。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/7ba6775a3b72447cb8b000d29c451fe9/2e486272414e4328a364dd1dd41976ee.jpg, createdBy=96881963893, createdName=Chong Yang, createdTime=Sat Feb 11 17:28:59 CST 2023, time=2023-02-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112132, encodeId=ffcd211213226, content=Required Reviews Completed状态到底要多久！！！！从5月1日到现在了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad6b6541939, createdName=ms9000000675256751, createdTime=Mon Jan 30 15:55:15 CST 2023, time=2023-01-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2091443, encodeId=ba6f209144334, content=under review 2周后，状态转为Required Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Sun Oct 02 10:25:09 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110678, encodeId=e4df21106e878, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌 经验分享：请问如何撤稿？投稿9个月没有动静，给编辑部发了3封催稿邮件从不回复。已经对此刊死心了，打算改投。请问如何撤稿？通过通讯作者邮箱给这个E-mail地址pancreasofc@ucla.edu告知撤稿就可以了吗？编辑部的人好像都死了，怎么问询也不会回邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Wed Jan 18 08:18:15 CST 2023, time=2023-01-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=548013, encodeId=20ee548013e7, content=请问有相似经验的小伙伴吗，pancreas投了快2个月了，还是submitted to journal ，发了邮件也没消息，想知道怎么回事？谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1eea2163064, createdName=120372d6m60(暂无昵称), createdTime=Sun Oct 08 19:20:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239524, encodeId=b343123952488, content=偏重的研究方向：胰腺炎;胰腺癌 经验分享：此刊慎投。投了4个月，一直是“Reviewer invited”状态，发邮件给推荐审稿人也不回复，气死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Thu Aug 18 14:56:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243394, encodeId=c0c91243394eb, content=审稿速度:6.0 经验分享：投了5个多月了，还没消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1e4839601, createdName=songyd, createdTime=Mon Sep 05 22:52:48 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103342, encodeId=f1b8210334264, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：以后不会再投了，影响因子低，周期长，编辑也从来不理人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80bd1682976, createdName=DengLH, createdTime=Tue Nov 29 17:20:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2095775, encodeId=eb7f2095e75df, content=请问一下，投稿过程中总是addition information出问题是怎么回事啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad98393587, createdName=ms9000001100975757, createdTime=Mon Oct 24 11:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=)]

2022-09-05 songyd

审稿速度:6.0
经验分享：投了5个多月了，还没消息。。

97 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=804780, encodeId=a609804e8057, content=收case report嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e8e5400378, createdName=ms4000001486715549, createdTime=Mon Jul 27 20:15:44 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114136, encodeId=2e6b2114136c9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌;胰腺外科;胰腺 经验分享：避坑提示：《Pancreas》这个杂志真的不能投，2022年1月18号投，2023年1月10号接收（online还遥遥无期），回修1次，提了一大堆无聊的格式和语言问题，中途催了无数次状态，邮件不回，电话不接。当年还算胰腺病领域的老牌杂志，所有杂志都在IF看涨，现在一年只出10期（今天才出到去年9月份），混到中科院4区4类。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/7ba6775a3b72447cb8b000d29c451fe9/2e486272414e4328a364dd1dd41976ee.jpg, createdBy=96881963893, createdName=Chong Yang, createdTime=Sat Feb 11 17:28:59 CST 2023, time=2023-02-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112132, encodeId=ffcd211213226, content=Required Reviews Completed状态到底要多久！！！！从5月1日到现在了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad6b6541939, createdName=ms9000000675256751, createdTime=Mon Jan 30 15:55:15 CST 2023, time=2023-01-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2091443, encodeId=ba6f209144334, content=under review 2周后，状态转为Required Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Sun Oct 02 10:25:09 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110678, encodeId=e4df21106e878, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌 经验分享：请问如何撤稿？投稿9个月没有动静，给编辑部发了3封催稿邮件从不回复。已经对此刊死心了，打算改投。请问如何撤稿？通过通讯作者邮箱给这个E-mail地址pancreasofc@ucla.edu告知撤稿就可以了吗？编辑部的人好像都死了，怎么问询也不会回邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Wed Jan 18 08:18:15 CST 2023, time=2023-01-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=548013, encodeId=20ee548013e7, content=请问有相似经验的小伙伴吗，pancreas投了快2个月了，还是submitted to journal ，发了邮件也没消息，想知道怎么回事？谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1eea2163064, createdName=120372d6m60(暂无昵称), createdTime=Sun Oct 08 19:20:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239524, encodeId=b343123952488, content=偏重的研究方向：胰腺炎;胰腺癌 经验分享：此刊慎投。投了4个月，一直是“Reviewer invited”状态，发邮件给推荐审稿人也不回复，气死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Thu Aug 18 14:56:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243394, encodeId=c0c91243394eb, content=审稿速度:6.0 经验分享：投了5个多月了，还没消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1e4839601, createdName=songyd, createdTime=Mon Sep 05 22:52:48 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103342, encodeId=f1b8210334264, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：以后不会再投了，影响因子低，周期长，编辑也从来不理人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80bd1682976, createdName=DengLH, createdTime=Tue Nov 29 17:20:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2095775, encodeId=eb7f2095e75df, content=请问一下，投稿过程中总是addition information出问题是怎么回事啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad98393587, createdName=ms9000001100975757, createdTime=Mon Oct 24 11:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=)]

2022-11-29 DengLH 来自四川省

审稿速度:24.0 | 投稿命中率:50.0
经验分享：以后不会再投了，影响因子低，周期长，编辑也从来不理人

93 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=804780, encodeId=a609804e8057, content=收case report嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e8e5400378, createdName=ms4000001486715549, createdTime=Mon Jul 27 20:15:44 CST 2020, time=2020-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114136, encodeId=2e6b2114136c9, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌;胰腺外科;胰腺 经验分享：避坑提示：《Pancreas》这个杂志真的不能投，2022年1月18号投，2023年1月10号接收（online还遥遥无期），回修1次，提了一大堆无聊的格式和语言问题，中途催了无数次状态，邮件不回，电话不接。当年还算胰腺病领域的老牌杂志，所有杂志都在IF看涨，现在一年只出10期（今天才出到去年9月份），混到中科院4区4类。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/7ba6775a3b72447cb8b000d29c451fe9/2e486272414e4328a364dd1dd41976ee.jpg, createdBy=96881963893, createdName=Chong Yang, createdTime=Sat Feb 11 17:28:59 CST 2023, time=2023-02-11, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2112132, encodeId=ffcd211213226, content=Required Reviews Completed状态到底要多久！！！！从5月1日到现在了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad6b6541939, createdName=ms9000000675256751, createdTime=Mon Jan 30 15:55:15 CST 2023, time=2023-01-30, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2091443, encodeId=ba6f209144334, content=under review 2周后，状态转为Required Reviews Completed, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e62e5505390, createdName=瑶瑶童, createdTime=Sun Oct 02 10:25:09 CST 2022, time=2022-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110678, encodeId=e4df21106e878, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：胰腺癌 经验分享：请问如何撤稿？投稿9个月没有动静，给编辑部发了3封催稿邮件从不回复。已经对此刊死心了，打算改投。请问如何撤稿？通过通讯作者邮箱给这个E-mail地址pancreasofc@ucla.edu告知撤稿就可以了吗？编辑部的人好像都死了，怎么问询也不会回邮件。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Wed Jan 18 08:18:15 CST 2023, time=2023-01-18, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=548013, encodeId=20ee548013e7, content=请问有相似经验的小伙伴吗，pancreas投了快2个月了，还是submitted to journal ，发了邮件也没消息，想知道怎么回事？谢谢了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=351, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1eea2163064, createdName=120372d6m60(暂无昵称), createdTime=Sun Oct 08 19:20:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239524, encodeId=b343123952488, content=偏重的研究方向：胰腺炎;胰腺癌 经验分享：此刊慎投。投了4个月，一直是“Reviewer invited”状态，发邮件给推荐审稿人也不回复，气死人了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15a31892640, createdName=ms1859105519819171, createdTime=Thu Aug 18 14:56:19 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243394, encodeId=c0c91243394eb, content=审稿速度:6.0 经验分享：投了5个多月了，还没消息。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=97, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e1e4839601, createdName=songyd, createdTime=Mon Sep 05 22:52:48 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103342, encodeId=f1b8210334264, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：以后不会再投了，影响因子低，周期长，编辑也从来不理人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80bd1682976, createdName=DengLH, createdTime=Tue Nov 29 17:20:20 CST 2022, time=2022-11-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2095775, encodeId=eb7f2095e75df, content=请问一下，投稿过程中总是addition information出问题是怎么回事啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad98393587, createdName=ms9000001100975757, createdTime=Mon Oct 24 11:53:50 CST 2022, time=2022-10-24, status=1, ipAttribution=)]

2022-10-24 ms9000001100975757

请问一下，投稿过程中总是addition information出问题是怎么回事啊

78 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务